Table 3.
Models | Training set (n = 1200) | Validation set (n = 1118) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUC (95%CI) | P | Youdan | Sensitivity | Specificity | PPV | NPV | AUC (95% CI) | P | Youdan | Sensitivity | Specificity | PPV | NPV | |
Nomogram | 0.863 (0.840–0.886) | Ref | 0.576 | 0.798 | 0.778 | 0.513 | 0.929 | 0.864 (0.841–0.887) | Ref | 0.583 | 0.922 | 0.661 | 0.448 | 0.966 |
FLI | 0.862 (0.838–0.886) | 0.850 | 0.564 | 0.787 | 0.777 | 0.508 | 0.926 | 0.866 (0.843–0.889) | 0.772 | 0.600 | 0.851 | 0.748 | 0.502 | 0.944 |
HSI | 0.835 (0.808–0.862) | 0.019 | 0.548 | 0.812 | 0.736 | 0.474 | 0.931 | 0.833 (0.806–0.859) | 0.006 | 0.514 | 0.817 | 0.697 | 0.446 | 0.927 |
AIP | 0.782 (0.752–0.811) | < 0.001 | 0.444 | 0.761 | 0.683 | 0.413 | 0.907 | 0.773 (0.746–0.808) | < 0.001 | 0.444 | 0.767 | 0.677 | 0.415 | 0.907 |
AUROC area under the receiver operating characteristics, PPV positive predictive value, NPV negative predictive value, NAFLD nonalcoholic fatty liver disease, FLI fatty liver index, HSI hepatic steatosis index, AIP atherogenic index of plasma, Ref reference